4.1 Review

The Evolution of Spacers and Valved Holding Chambers

Journal

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/jamp.2013.1076

Keywords

spacer; valved holding chamber; pMDI accessory device; patent; electrostatic; inhalation delay; adherence

Funding

  1. Respironics Respiratory Drug Delivery (UK) Ltd.

Ask authors/readers for more resources

Spacers and valved holding chambers (VHCs) are pressurized metered dose inhaler (pMDI) accessory devices, designed to overcome problems that patients commonly experience when administering aerosol via a pMDI. Spacers were developed in direct response to patient-related issues with pMDI technique, particularly, poor coordination between actuation and inhalation, and local side-effects arising from oropharyngeal deposition. Current clinical guidelines indicate the need for widespread prescription and use of spacers, but, despite their apparent ubiquity, the devices themselves are, unfortunately, all too commonly disused by patients. An understanding of the background from which spacers developed, and the key factors influencing the optimization of the spacer and the later VHC, is crucial to developing an appreciation of the potential of these devices, both contemporary and future, for improving the delivery of pressurized aerosols to patients. This review, informed by a full patent search and an extensive scientific literature review, takes into account the clinical and laboratory evidence, commercial developments, and the sometimes serendipitous details of scientific anecdotes to forma comprehensive perspective on the evolution of spacers, from their origins, in the early days of the pMDI, up to the present day.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available